Feed PAVM
PA

PAVmed Inc. PAVM · NASDAQ

$1.70 +8.28% (+$0.13)

Market cap
$13.6M
Enterprise value
$26.9M
P/E
-
Forward P/E
-
PEG
-
P/S
121.4x
P/FCF
-
EV/EBITDA
-
ROIC
-72.8%
Gross margin
-254.5%
Net margin
-10,794.6%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
0.54
Free float
51.9%

About the company

PAVmed Inc. (PAVM) is an American company focused on innovation in the field of healthcare technologies. The company specializes in the development and commercialization of medical devices and technologies with the potential to improve diagnostics and treatment of various medical conditions. PAVmed focuses on creating patented products and technologies that have the potential to transform the way certain medical procedures are performed. With its innovative approach, PAVmed can attract investors seeking opportunities in healthcare innovation and advanced medical technologies. Shares of PAVmed Inc. (PAVM) could present an intriguing investment opportunity.

Sector

Healthcare

Industry

Medical - Devices

CEO

Lishan Aklog

Employees

41

Headquarters

New York City

Valuation

Is today's price reasonable?

  • What speaks for it: The share price is below the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Revenue fell by 43% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What to watch: The company made a loss over the last 12 months.

Financial health

Can it carry its debt?

  • What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

  • What speaks for it: The price moves less than the market (beta 0.54).

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy